MISSION&VISIONMAJOROBJECTIVEMISSIONCORE DIRECTIONS FOR RESEARCH & BUSINESS PROJECTSBiotechnology to Create New Economic Growth EnginesDevelopment of BINT(BT, IT, NT) convergence technologyDevelopment of disease controlling technologies using stem cells and antibodiesIdentification of targets and development of candidate materials for the diagnosisand treatment of five major diseasesDevelopment of the generic technology for cell factories and biomaterialsVISIONBiotechnology to Address the National AgendaTechnology Development for infection controlFostering R&D on cranial nerves and the aging societyDevelopment of biomass and bioenergy technology6KRIBB Annual Report 2010National Infrastructure to Enhance National Biotechnology CompetitivenessImprovement of the infrastructure for compiling, managing and utilizing bio resources and dataConsolidation of the infrastructure for biological assessment and GMO risk assessmentCORE DIRECTIONS FOR ORGANIZATIONAL MANAGEMENTImprovement of the Framework to Facilitate R&DIntroduction of an open R&D system and acquisition of competitive human resourcesStrategical selection and concentrationExpansion of global cooperationContributions to the Society and the CountryImprovement of the ability to respond to future Biotechnology demandsPromotion of demand-based R&D and commercialization of technologiesRaising public awareness of Biotechnology and public interest in scienceImprovement of the Management EfficiencyPromotion of result- and objective-oriented managementAugmentation and efficient allocation of the R&D budgetMaintenance of an up-to-date data and facility infrastructure7KRIBB Annual Report 2010
GENERALINFORMATIONFOUNDATION BASISArticle 8, Act on the Establishment, Management and Promotion of Government-fundedResearch InstitutionsHUMAN RESOURCESDescriptions Executives Researchers Engineers Administrators Technicians TotalRegular employees 1 208 52 32 46 338KEY FUNCTIONSAdvanced R&D and development & distribution of generic technologies in bioscience andBUDGET (Unit : Millions of Won)biotechnologyRevenueExpenditureFuture bio-convergence, personalized bio-medicine, bio green technology, bio-basedDescriptionsDescriptionsnational agendaGovernment funds 56,675Personal expenses 24,516Public infrastructure development support for research on bioscience at home and abroadPublic infrastructure development support, national policy think-tank, specializededucation and trainingInstitute revenues 57,872Government-funded projects 51,138Privately-funded projects 2,334Other research projects 600Direct research expenses 72,961Major projects 29,283Government-funded projects 40,454Privately-funded projects 1,724Technology supports 1,200Other research projects 600Royalties 1,200Technology supports 900Others 1,400General and administrative expenses 6,1108Total 114,547Facility expenses 9,348Others 1,6129KRIBB Annual Report 2010HISTORYFEB. 1985JUL. 1990MAR. 1995Established as a Genetic Engineering Research Center (Seoul)Moved to Daejeon, Current LocationChanged its name to the Korea Research Institute of Bioscience &Biotechnology (KRIBB)FACILITIES (Unit : m 2 )Daejeon HeadquartersSite 100,978Building 53,448Total 114,547Ochang Branch InstituteSite 212,258Building 26,548Research 26,548KRIBB Annual Report 2010MAY. 1999Became an independent legal entity under the Korea ResearchCouncil of Fundamental Science & Technology (KRCF)Main Building 11,871Research Building 17,008Resource Building 6,554National Primates Research Center 4,774Bio-Evaluation Center 9,636Biotherapeutic Research Center 11,558SEP. 2005Established Ochang Branch InstituteVenture Building 3,044Native plant Building(1) 1,134Others 580NOV. 2006Established Jeonbuk Branch InstituteNative plant Building(2) 1,077Cafeteria Building 2,646Green house research building, etc. 1,765Residence 6,879Jeonbuk Branch InstituteSite 18,522Apartment 1,900Research Building 6,125Dormitory 4,979Administrative building and Dormitory 2,811